Compare DOUG & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOUG | INGN |
|---|---|---|
| Founded | 1911 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.3M | 173.5M |
| IPO Year | 2021 | 2013 |
| Metric | DOUG | INGN |
|---|---|---|
| Price | $1.74 | $6.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.25 |
| AVG Volume (30 Days) | ★ 339.8K | 335.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.68 | 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $955,578,000.00 | $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $1.53 | $5.34 |
| 52 Week High | $3.19 | $9.13 |
| Indicator | DOUG | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 51.58 |
| Support Level | $1.69 | $6.00 |
| Resistance Level | $1.86 | $6.77 |
| Average True Range (ATR) | 0.06 | 0.27 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 44.83 | 80.00 |
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.